CN Stock MarketDetailed Quotes

603205 Jianerkang Medical

Watchlist

0.00
0.000.00%

Market Closed Oct 30 09:30 CST

0Market Cap0.00P/E (TTM)

Jianerkang Medical Key Stats

Cash Flow

All

YOY

Hide blank lines

(Q6)Jun 30, 2024

(Q3)Mar 31, 2024

(FY)Dec 31, 2023

(Q9)Sep 30, 2023

(Q6)Jun 30, 2023

(Q3)Mar 31, 2023

(FY)Dec 31, 2022

(Q9)Sep 30, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

Total operating revenue

5.97%504.53M

0.48%211.89M

-5.46%1.03B

-6.45%711.33M

-7.68%476.12M

210.88M

39.79%1.09B

760.4M

515.72M

-51.83%782.04M

Operating revenue

5.97%504.53M

0.48%211.89M

-5.46%1.03B

-6.45%711.33M

-7.68%476.12M

--210.88M

39.79%1.09B

--760.4M

--515.72M

-51.83%782.04M

Other operating revenue

433.41%3.19M

----

-49.55%1.4M

----

--598.85K

----

47.32%2.77M

----

-77.86%1.88M

Total operating cost

7.44%434.77M

-1.91%884.5M

-6.01%404.68M

30.28%901.69M

430.54M

-35.39%692.15M

Operating cost

5.87%390.48M

----

-3.81%797.57M

----

-8.31%368.83M

----

38.79%829.19M

----

--402.25M

-31.77%597.42M

Operating tax surcharges

5.92%4.33M

----

-13.23%7.89M

----

11.54%4.09M

----

41.45%9.09M

----

--3.67M

-43.91%6.43M

Operating expense

9.57%13.41M

----

0.15%26.01M

----

25.17%12.24M

----

31.40%25.97M

----

--9.78M

-71.17%19.76M

Administration expense

5.77%15.72M

----

-8.71%28.63M

----

2.24%14.86M

----

-1.67%31.36M

----

--14.54M

-4.12%31.89M

Financial expense

30.70%-8.63M

----

58.32%-12.18M

----

22.13%-12.45M

----

-464.66%-29.21M

----

---15.98M

-74.43%8.01M

-Interest expense (Financial expense)

----

-60.77%650.76K

----

-18.73%420.1K

----

129.74%1.66M

----

--516.94K

-93.86%721.97K

-Interest Income (Financial expense)

-229.23%-4.49M

----

-69.73%-4.35M

----

-2,949.52%-1.36M

----

-2,572.14%-2.57M

----

---44.74K

87.74%-96K

Research and development

13.71%19.46M

----

3.65%36.59M

----

5.00%17.11M

----

23.26%35.3M

----

--16.3M

-43.85%28.64M

Credit Impairment Loss

120.29%1.48M

----

58.73%-6M

----

15.28%-7.32M

----

-375.52%-14.53M

----

---8.64M

-41.96%5.27M

Asset Impairment Loss

3.92%-4.04M

----

13.03%-4.72M

----

-32.80%-4.21M

----

-123.39%-5.42M

----

---3.17M

94.26%-2.43M

Other net revenue

95.98%-675.7K

7.92%-14.12M

-66.96%-16.81M

-181.93%-15.34M

-10.07M

180.57%18.72M

Fair value change income

----

---488.6K

----

Invest income

98.80%-195.4K

----

-15,829.52%-16.19M

----

-35,606.37%-16.23M

----

-70.56%102.93K

----

--45.71K

-89.84%349.63K

Asset deal income

--212.44K

----

100.97%29.4K

----

-2,388.85%-3.02M

----

---3.06M

2,831.93%132.15K

Other revenue

-82.97%1.86M

----

75.67%13.24M

----

130.57%10.95M

----

-51.03%7.54M

----

--4.75M

136.56%15.39M

Operating profit

26.43%69.08M

-23.44%134.9M

-27.26%54.63M

62.23%176.2M

75.1M

-79.47%108.61M

Add:Non operating Income

-96.95%222.65K

----

338.93%7.9M

----

8,499.48%7.3M

----

-95.66%1.8M

----

--84.87K

140,897.12%41.47M

Less:Non operating expense

78.09%37.65K

----

5.11%182.62K

----

-83.02%21.14K

----

-61.23%173.74K

----

--124.49K

-78.87%448.08K

Total profit

11.87%69.26M

-1.55%28.22M

-19.80%142.62M

-17.20%96.24M

-17.52%61.91M

28.66M

18.84%177.83M

116.22M

75.06M

-71.60%149.63M

Less:Income tax cost

-4.51%8.32M

----

-6.90%19.08M

----

-11.88%8.71M

----

13.83%20.49M

----

--9.88M

-87.38%18M

Net profit

14.55%60.94M

3.49%24.96M

-21.48%123.55M

-17.08%83.4M

-18.38%53.2M

24.12M

19.53%157.34M

100.58M

65.18M

-65.74%131.63M

Net profit from continuing operation

14.55%60.94M

----

-21.48%123.55M

----

--53.2M

----

19.53%157.34M

----

-65.74%131.63M

Net profit of parent company owners

14.55%60.94M

3.49%24.96M

-21.48%123.55M

-17.08%83.4M

-18.38%53.2M

--24.12M

19.53%157.34M

--100.58M

--65.18M

-65.74%131.63M

Earning per share

Basic earning per share

14.55%0.6771

----

-21.48%1.3727

----

-17.90%0.5911

----

19.54%1.7482

----

--0.72

-69.52%1.4625

Diluted earning per share

14.55%0.6771

----

-21.48%1.3727

----

-17.90%0.5911

----

19.54%1.7482

----

--0.72

-69.52%1.4625

Other composite income

Total composite income

14.55%60.94M

-21.48%123.55M

-18.38%53.2M

19.53%157.34M

65.18M

-65.74%131.63M

Total composite income of parent company owners

14.55%60.94M

----

-21.48%123.55M

----

--53.2M

----

19.53%157.34M

----

-65.74%131.63M

Currency Unit

CNY

Accounting Standards

CAS (2007)

Audit Opinions

Unqualified opinion

Auditor

Tianheng Certified Public Accountants (Special General Partnership)

	(Q6)Jun 30, 2024	(Q3)Mar 31, 2024	(FY)Dec 31, 2023	(Q9)Sep 30, 2023	(Q6)Jun 30, 2023	(Q3)Mar 31, 2023	(FY)Dec 31, 2022	(Q9)Sep 30, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021
Total operating revenue	5.97%504.53M	0.48%211.89M	-5.46%1.03B	-6.45%711.33M	-7.68%476.12M	210.88M	39.79%1.09B	760.4M	515.72M	-51.83%782.04M
Operating revenue	5.97%504.53M	0.48%211.89M	-5.46%1.03B	-6.45%711.33M	-7.68%476.12M	--210.88M	39.79%1.09B	--760.4M	--515.72M	-51.83%782.04M
Other operating revenue	433.41%3.19M	----	-49.55%1.4M	----	--598.85K	----	47.32%2.77M	----	----	-77.86%1.88M
Total operating cost	7.44%434.77M		-1.91%884.5M		-6.01%404.68M		30.28%901.69M		430.54M	-35.39%692.15M
Operating cost	5.87%390.48M	----	-3.81%797.57M	----	-8.31%368.83M	----	38.79%829.19M	----	--402.25M	-31.77%597.42M
Operating tax surcharges	5.92%4.33M	----	-13.23%7.89M	----	11.54%4.09M	----	41.45%9.09M	----	--3.67M	-43.91%6.43M
Operating expense	9.57%13.41M	----	0.15%26.01M	----	25.17%12.24M	----	31.40%25.97M	----	--9.78M	-71.17%19.76M
Administration expense	5.77%15.72M	----	-8.71%28.63M	----	2.24%14.86M	----	-1.67%31.36M	----	--14.54M	-4.12%31.89M
Financial expense	30.70%-8.63M	----	58.32%-12.18M	----	22.13%-12.45M	----	-464.66%-29.21M	----	---15.98M	-74.43%8.01M
-Interest expense (Financial expense)	----	----	-60.77%650.76K	----	-18.73%420.1K	----	129.74%1.66M	----	--516.94K	-93.86%721.97K
-Interest Income (Financial expense)	-229.23%-4.49M	----	-69.73%-4.35M	----	-2,949.52%-1.36M	----	-2,572.14%-2.57M	----	---44.74K	87.74%-96K
Research and development	13.71%19.46M	----	3.65%36.59M	----	5.00%17.11M	----	23.26%35.3M	----	--16.3M	-43.85%28.64M
Credit Impairment Loss	120.29%1.48M	----	58.73%-6M	----	15.28%-7.32M	----	-375.52%-14.53M	----	---8.64M	-41.96%5.27M
Asset Impairment Loss	3.92%-4.04M	----	13.03%-4.72M	----	-32.80%-4.21M	----	-123.39%-5.42M	----	---3.17M	94.26%-2.43M
Other net revenue	95.98%-675.7K	0	7.92%-14.12M	0	-66.96%-16.81M	0	-181.93%-15.34M	0	-10.07M	180.57%18.72M
Fair value change income	----	----	---488.6K	----	----	----	----	----	----	----
Invest income	98.80%-195.4K	----	-15,829.52%-16.19M	----	-35,606.37%-16.23M	----	-70.56%102.93K	----	--45.71K	-89.84%349.63K
Asset deal income	--212.44K	----	100.97%29.4K	----	----	----	-2,388.85%-3.02M	----	---3.06M	2,831.93%132.15K
Other revenue	-82.97%1.86M	----	75.67%13.24M	----	130.57%10.95M	----	-51.03%7.54M	----	--4.75M	136.56%15.39M
Operating profit	26.43%69.08M		-23.44%134.9M		-27.26%54.63M		62.23%176.2M		75.1M	-79.47%108.61M
Add:Non operating Income	-96.95%222.65K	----	338.93%7.9M	----	8,499.48%7.3M	----	-95.66%1.8M	----	--84.87K	140,897.12%41.47M
Less:Non operating expense	78.09%37.65K	----	5.11%182.62K	----	-83.02%21.14K	----	-61.23%173.74K	----	--124.49K	-78.87%448.08K
Total profit	11.87%69.26M	-1.55%28.22M	-19.80%142.62M	-17.20%96.24M	-17.52%61.91M	28.66M	18.84%177.83M	116.22M	75.06M	-71.60%149.63M
Less:Income tax cost	-4.51%8.32M	----	-6.90%19.08M	----	-11.88%8.71M	----	13.83%20.49M	----	--9.88M	-87.38%18M
Net profit	14.55%60.94M	3.49%24.96M	-21.48%123.55M	-17.08%83.4M	-18.38%53.2M	24.12M	19.53%157.34M	100.58M	65.18M	-65.74%131.63M
Net profit from continuing operation	14.55%60.94M	----	-21.48%123.55M	----	--53.2M	----	19.53%157.34M	----	----	-65.74%131.63M
Net profit of parent company owners	14.55%60.94M	3.49%24.96M	-21.48%123.55M	-17.08%83.4M	-18.38%53.2M	--24.12M	19.53%157.34M	--100.58M	--65.18M	-65.74%131.63M
Earning per share
Basic earning per share	14.55%0.6771	----	-21.48%1.3727	----	-17.90%0.5911	----	19.54%1.7482	----	--0.72	-69.52%1.4625
Diluted earning per share	14.55%0.6771	----	-21.48%1.3727	----	-17.90%0.5911	----	19.54%1.7482	----	--0.72	-69.52%1.4625
Other composite income
Total composite income	14.55%60.94M		-21.48%123.55M		-18.38%53.2M		19.53%157.34M		65.18M	-65.74%131.63M
Total composite income of parent company owners	14.55%60.94M	----	-21.48%123.55M	----	--53.2M	----	19.53%157.34M	----	----	-65.74%131.63M
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)	CAS (2007)
Audit Opinions	--	--	Unqualified opinion	--	--	--	Unqualified opinion	--	--	Unqualified opinion
Auditor	--	--	Tianheng Certified Public Accountants (Special General Partnership)	--	--	--	Tianheng Certified Public Accountants (Special General Partnership)	--	--	Tianheng Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data

603205 Jianerkang Medical

Jianerkang Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Analysis

Analyst Rating

Price Target